Newly developed anti-malarial medicine treats toxoplasmosis
User rating: 4 / 5 after 4 vote(s)
The DHFR enzyme from the parasites that cause malaria (blue) overlaid with the enzyme from the parasites that cause toxoplasmosis (red), with those residues involved in significant changes in the presence of the drug displayed in stick format. In addition both enzymes have their surface displayed. For both figures the modelled inhibitor is colored yellow, red, green, blue and cyan for carbon, oxygen, chlorine, nitrogen and fluorine, respectively. Credit: Milhous-Jacobus-McLeod
Full story »
|

PhysOrg Forum
Video
Editorials
Free Magazines
Newsletter
Goto Archive
Suggest a story idea
Send feedback